Sign In
Buy CNS
$80.79
-1.71 (-2.07%)
At Close: Jul 21, 2026
Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
04:28pm, Wednesday, 02'nd Oct 2024
VANCOUVER, British Columbia and BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developin
Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
08:03am, Tuesday, 01'st Oct 2024
CORAL GABLES, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, dev
Cohen & Steers Closed-End Funds Declare Distributions for October, November, and December 2024
06:00pm, Monday, 30'th Sep 2024
NEW YORK , Sept. 30, 2024 /PRNewswire/ -- The Boards of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for October, November, and December 2024, as summariz
Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
04:00pm, Monday, 30'th Sep 2024
NEWTON, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyl
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
04:52pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources o
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
04:50pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
04:49pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the s
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
04:49pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the di
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
04:46pm, Friday, 27'th Sep 2024
NEW YORK , Sept. 27, 2024 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of
Corero Network Security To Hold Investor Calls Following Strong H1 2024 Results
07:00am, Tuesday, 24'th Sep 2024
LONDON , Sept. 24, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, will hold investor calls this week to discus
CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
09:00am, Monday, 23'rd Sep 2024
Webcast presentation on Wednesday, September 25th at 1:55 PM CEST HOUSTON, TX / ACCESSWIRE / September 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical
CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
09:00am, Thursday, 12'th Sep 2024
HOUSTON, TX / ACCESSWIRE / September 12, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pr
Cohen & Steers Joins SUBSCRIBE Alternative Investment Platform to Expand Private Real Estate Access for Private Wealth Channel
06:00am, Thursday, 12'th Sep 2024
NEW YORK , Sept. 12, 2024 /PRNewswire/ -- SUBSCRIBE, a leading operating system for alternative investments serving institutional investors, wealth management firms, and fund managers, announced today
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows For August 2024
04:20pm, Tuesday, 10'th Sep 2024
NEW YORK , Sept. 10, 2024 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $88.1 billion as of August 31, 2024, an increase of $3.5 billion from a
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
09:05am, Wednesday, 04'th Sep 2024
HOUSTON, TX / ACCESSWIRE / September 4, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri
